Technology | Magnetic Resonance Imaging (MRI) | February 17, 2017

FDA Clears Siemens Magnetom Sempra MRI System

Cost-efficient system includes standardized, automated workflows for nearly 75 percent of MRI exams

Siemens Healthineers, Magnetom Sempra MRI system, FDA approval, RSNA 2017

February 17, 2017 — Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the Magnetom Sempra 60-cm 1.5 Tesla (1.5T) magnetic resonance imaging (MRI) system.

Siemens said the Magnetom Sempra is distinguished by its low operating costs, innovative technologies, and full-coverage service contract, which help radiological practices and groups, as well as small- and medium-sized hospitals, operate profitably despite rising industry cost pressures. Additionally, the system’s standardized workflows are designed to help facilities achieve consistent, user- and patient-independent levels of quality.

With Day optimizing throughput (Dot) workflow engines, the system enables the user to adjust to each clinical case and to the condition of each patient while simultaneously maintaining exam standardization. The system comes equipped with three Dot engines to automate and streamline workflow for brain, spine and large joint procedures. These Dot engines cover roughly three-quarters of the average exam volume and help users increase productivity in addition to avoiding unnecessary and costly repeat scans.

The Magnetom Sempra includes applications that enable facilities to respond to competitive pressure and adapt to changing market demands. For example, facilities can scan in the presence of MRI-safe metallic implants with improved visualization of surrounding soft tissue, including hip and knee implants. The system’s software platform includes the company’s etablished Quiet Suite technology, which can reduce sound pressure by up to 97 percent in brain and musculoskeletal exams while delivering high-quality images. Quiet Suite technology can benefit anxious patients and offer a more positive exam experience.

With its equipped Dot engines, the Magnetom Sempra enables users to perform exams in just 10 minutes – including a brain exam, from patient positioning to exam completion – using time- and image-optimized protocols that cover most commonly scanned body parts.

To reduce overall operating costs, the system offers Eco-Power technology, which monitors and controls the magnet-cooling helium to reduce energy consumption by up to 30 percent compared to the system’s normal mode. Zero Helium boil-off technology, a supplementary feature, prevents helium evaporation, so operators can avoid expensive helium refills and resultant downtimes.

For more information: www.usa.siemens.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Machine Learning IDs Markers to Help Predict Alzheimer's

Neurologists use structural and diffusion magnetic resonance imaging (MRI) to identify changes in brain tissue (both gray and white matter) that are characteristic of Alzheimer's disease and other forms of dementia. The MRI images are analyzed using morphometry and tractography techniques, which detect changes in the shape and dimensions of the brain and in the tissue microstructure, respectively. In this example, the images show the normal brain of an elderly patient. Image courtesy of Jiook Cha.

News | Neuro Imaging | September 20, 2018
New research has shown a combination of two different modes of magnetic resonance imaging (MRI), computer-based...
Ingenia Ambition X 1.5T MR. This innovation is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter, and simpler path to enabling a confident diagnosis
News | Magnetic Resonance Imaging (MRI) | September 14, 2018
Philips, a global leader in health technology, launched the Ingenia Ambition X 1.5T MR.
Veye Chest version 2
News | Lung Cancer | September 11, 2018
Aidence, an Amsterdam-based medical AI company, announced that Veye Chest version 2, a class IIa medical device, has
Sponsored Content | Case Study | Magnetic Resonance Imaging (MRI) | September 07, 2018 | By Sabine Sartoretti, M.D.
As soon as the Compressed SENSE technology became available to the MRI team at Kantonsspital Winterthur (Switzerland),...

Image courtesy of Philips Healthcare

Feature | Magnetic Resonance Imaging (MRI) | September 06, 2018 | By Melinda Taschetta-Millane
According to the Prescient & Strategic Intelligence report, “Global Magnetic Resonance Imaging (MRI) Market Size,...
Brain Iron Levels May Predict Multiple Sclerosis Disabilities
News | Neuro Imaging | August 31, 2018
A new, highly accurate magnetic resonance imaging (MRI) technique can monitor iron levels in the brains of multiple...
Study Finds Multiple Sclerosis Drug Slows Brain Shrinkage

An NIH-funded clinical trial suggested that the anti-inflammatory drug ibudilast may slow brain shrinkage caused by progressive MS. Image courtesy of Robert J. Fox, M.D., Cleveland Clinic.

News | Neuro Imaging | August 30, 2018
August 30, 2018 — Results from a clinical...
Rapid Cardiac MRI Technique May Cut Costs, Boost Care in Developing World
News | Magnetic Resonance Imaging (MRI) | August 29, 2018
A newly developed rapid imaging protocol quickly and cheaply diagnosed heart ailments in patients in Peru, according to...
iSchemaView RAPID Technology Now Installed in More Than 500 Stroke Centers
News | Neuro Imaging | August 27, 2018
iSchemaView announced that more than 575 stroke centers in 22 countries have selected the RAPID advanced imaging...